{"id":"NCT01438710","sponsor":"Veloxis Pharmaceuticals","briefTitle":"Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)","officialTitle":"Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2012-08","completion":"2015-07","firstPosted":"2011-09-22","resultsPosted":"2015-05-08","lastUpdate":"2015-10-01"},"enrollment":44,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Renal Failure","Tremors"],"interventions":[{"type":"DRUG","name":"Prograf","otherNames":["tacrolimus"]},{"type":"DRUG","name":"LCP-Tacro","otherNames":["tacrolimus"]}],"arms":[{"label":"LCP-Tacro","type":"EXPERIMENTAL"},{"label":"Prograf","type":"EXPERIMENTAL"}],"summary":"This study will evaluate and measure symptomatic hand tremor in stable kidney transplant subjects on Prograf or generic tacrolimus maintenance therapy at baseline (pre-conversion) and following conversion to LCP-Tacro. This study will also evaluate the safety of LCP-Tacro compared with Prograf or generic tacrolimus","primaryOutcome":{"measure":"Evaluation of Hand Tremor and Stable Kidney Transplant Patients When Switched From Prograf to LCP-Tacro.","timeFrame":"14 days","effectByArm":[{"arm":"LCP-Tacro","deltaMin":25.3,"sd":9.472}],"pValues":[{"comp":"OG000","p":"0.0048"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":41},"commonTop":["Oedema peripheral","Nausea","Cardiac Murmur","Hyperkalaemia"]}}